| Aggregation INSTRUMENTS |
| BIO/DATA CORPORATION |
An ISO 13485:2003, 9001:2000 Registered Company
| AGGREGATION |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
Bio/Data Corporation is a global leader in the development, design, and manufacturer of light
transmission aggregometers, the gold standard for platelet function testing. Test results
provide a vital insight into platelet pathophysiology enabling medical professionals to monitor
platelet function, to conduct special test procedures for HIT and RIPA, and to diagnose various
stages of abnormal platelet function and hemostasis disorders, including Sticky Platelet
Syndrome, von Willebrand Disease, and Glanzmann's Disease, or to monitor the use of
antiplatelet drugs like Plavix and aspirin (when used as aspirin therapy). The limited window of
time for actual testing of platelets creates a demand for streamlined instrument operation.
Those laboratories wanting to reduce platelet function assay variability and optimize patient
care, choose Bio/Data Corporation.
Bio/Data Corporation provides the laboratory with the tools to perform platelet function testing in
the repeatable and consistent manner required to generate accurate results for clinical and
research use.
Take Advantage of Bio/Data’s Innovation in Platelet Function and Aggregation Testing:
transmission aggregometers, the gold standard for platelet function testing. Test results
provide a vital insight into platelet pathophysiology enabling medical professionals to monitor
platelet function, to conduct special test procedures for HIT and RIPA, and to diagnose various
stages of abnormal platelet function and hemostasis disorders, including Sticky Platelet
Syndrome, von Willebrand Disease, and Glanzmann's Disease, or to monitor the use of
antiplatelet drugs like Plavix and aspirin (when used as aspirin therapy). The limited window of
time for actual testing of platelets creates a demand for streamlined instrument operation.
Those laboratories wanting to reduce platelet function assay variability and optimize patient
care, choose Bio/Data Corporation.
Bio/Data Corporation provides the laboratory with the tools to perform platelet function testing in
the repeatable and consistent manner required to generate accurate results for clinical and
research use.
Take Advantage of Bio/Data’s Innovation in Platelet Function and Aggregation Testing:
- Screen at-risk pre-surgical patients to determine the probability of excessive bleeding
during an invasive procedure.
- Identify and diagnose platelet dysfunction in those with genetic or acquired
bleeding disorders.
- Monitor antiplatelet therapy given to select patients after a stroke or heart attack to
help inhibit blood clotting.
- Detect aspirin resistance in patients who have had cardiovascular incident.
- Monitor platelet function during cardiopulmonary bypass surgery and cardiac
catherization.
| Aggregation REAGENTS |
| Aggregation ACCESSORIES |
| Aggregation SUPPLEMENTAL TECHNICAL BULLETINS |
| An ISO 13485:2003, 9001:2000 Registered Company |
155 Gibraltar Road, PO Box 347, Horsham, PA 19044-0347 USA
(215) 441-4000 Worldwide / (800) 257-3282 USA / (215) 443-8820 Fax Worldwide
Website: www.biodatacorp.com / Email: customer.service@biodatacorp.com
(215) 441-4000 Worldwide / (800) 257-3282 USA / (215) 443-8820 Fax Worldwide
Website: www.biodatacorp.com / Email: customer.service@biodatacorp.com
 | |  | |  | |  |
 | |  |